What are the Basel Statements?
Hospital pharmacists from around the world met in Basel, Switzerland, in 2008, to discuss the future of their sector. This historic two-day meeting, hosted by FIP’s Hospital Pharmacy Section, came to a consensus over 75 statements reflecting their vision of practice: the Basel Statements.
The Basel Statements cover all areas of the medicine use process in hospitals, from procurement to monitoring.
In 2014, hospital pharmacists again gathered, this time in Bangkok, Thailand, to input into future practice through updating the statements. The latest version of the Basel Statements was launched in September 2015. There are now 65 statements.
What the statements cover
The Basel Statements can be split into seven areas:
Link to Library
For the full statements document click here.
The Hospital Pharmacy Section has created a Basel Statement self-assessment survey to measure your hospital's services compared to the Basel Statements. The self-assessment tool also allows you to take the survey again over time to see the progress after improvements are made. In addition, the self-assessment tool allows you to compare your hospital's pharmacy services to other hospitals that you choose.
A recording of a Webinar with very helpful tips to complete the survey is posted here.
The Basel Statement Self-Assessment survey is available here.
The Basel Statements have been used in hospitals around the world:
|Western Pacific Region||St Mary's Lacor Hospital, Uganda|
You can access to the Basel statements translations here.
Resources to aid and monitor implementation:
About the revisions
Basel Statement Revisions (2015) Webinar
European Statements — The Basel Statements adapted to the European region The European Statements of Hospital Pharmacy. Eur J Hosp Pharm 2014;21:256-8.)
Further information on how the European Statements were developed can be found here
Use of the 2008 Basel consensus statements to assess, realign, and monitor pharmacy practice at a tertiary care hospital in northern Uganda: illustrative case study. (Poh J, Vaillancourt R, Lamarre D and Oyella J. Can J Hosp Pharm 2013;66:318-27.)
Monitoring influences on prescribing
1. Survey on Formularies Systems and Pharmacy and Therapeutics Committees
Comparative results for the Western Pacific region: Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
Penm J, Chaar B, Dechun J, Moles R. Am J Health-Syst Pharm 2013;70:967-79.
2. Survey on Clinical Pharmacy Services
Comparative results for the Western Pacific region: Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements. Penm J, Chaar B, Moles R. Int J Clin Pharm 2015;37(3):485-496.
The FIP Hospital Pharmacy Section encourages the republication of the Executive Summary of the 2008 Global Conference on the Future of Hospital Pharmacy in other journals, and the translation of the Basel Statements and other components of the conference proceedings into other languages. For our policy on reprinting, republishing and translating the statements, click here.
If you have any questions about the Basel Statements, contact Dr Rebekah Moles, HPS secretary: firstname.lastname@example.org